| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
1279 |
| issn |
1527-3792
0022-5347 |
| issueIdentifier |
4 |
| pageRange |
1279-1279 |
| publicationName |
The Journal of urology |
| startingPage |
1279 |
| bibliographicCitation |
Griebling TL. Re: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis. J Urol. 2011 Apr;185(4):1279. doi: 10.1016/s0022-5347(11)60289-9. PMID: 22098960. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54eed6483c369526006e6bc1559e7378 |
| date |
201104 |
| identifier |
https://doi.org/10.1016/s0022-5347%2811%2960289-9
https://pubmed.ncbi.nlm.nih.gov/22098960 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1527-3792
https://portal.issn.org/resource/ISSN/0022-5347
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5331 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Re: The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis |
| discusses |
http://id.nlm.nih.gov/mesh/M0472480
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0011048 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D050071Q000627
http://id.nlm.nih.gov/mesh/D007093Q000627
http://id.nlm.nih.gov/mesh/D010024Q000517
http://id.nlm.nih.gov/mesh/D011471Q000628
http://id.nlm.nih.gov/mesh/D001851Q000517
http://id.nlm.nih.gov/mesh/D004164Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7077
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 |